MedPath

Vdyne, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (100.0%)

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

Not Applicable
Recruiting
Conditions
Tricuspid Regurgitation
Tricuspid Valve Disease
Tricuspid Valvular Disorders
First Posted Date
2023-05-08
Last Posted Date
2025-08-15
Lead Sponsor
VDyne, Inc.
Target Recruit Count
30
Registration Number
NCT05848284
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Los Robles Hospital and Medical Center, Thousand Oaks, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Henry Ford Hospital, Detriot, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States

and more 7 locations

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Not Applicable
Recruiting
Conditions
Tricuspid Regurgitation
Tricuspid Valve Disease
Tricuspid Valvular Disorders
First Posted Date
2023-04-04
Last Posted Date
2025-11-03
Lead Sponsor
VDyne, Inc.
Target Recruit Count
120
Registration Number
NCT05797519
Locations
๐Ÿ‡ฉ๐Ÿ‡ฐ

University Hospital of Copenhagen, Copenhagen, Denmark

๐Ÿ‡ณ๐Ÿ‡ฑ

St Antonius Hospital, Nieuwegein, Netherlands

๐Ÿ‡ธ๐Ÿ‡ช

Lund University Skรฅne University Hospital, Lund, Sweden

and more 18 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.